Institutional investors in Sagimet Biosciences Inc. (NASDAQ:SGMT) see US$36m decrease in market cap last week, although long-term gains have benefitted them.

9 investors hold a 53% majority stake in Sagimet Biosciences Inc. (NASDAQ: SGMT). Institutional investors have the largest ownership at 40%, impacting market cap fluctuations. Analysts' forecasts and institutional ownership trends can provide insights for investors.